Beijing Med-Pharm Chief Financial Officer Fred Powell: An Interview With PharmAsia News (Part 2 of 2)
This article was originally published in The Pink Sheet Daily
Executive Summary
Powell discusses the importance of distribution in the Chinese pharmaceutical market, how China’s reimbursement situation contrasts with that of the U.S., and his firm’s approach to working with the countries regulators.
You may also be interested in...
Beijing Med-Pharm Chief Financial Officer Fred Powell: An Interview With PharmAsia News (Part 1 of 2)
Exec discusses the firm’s business model, how distribution figures into the equation, and how Beijing Med-Pharm is broadening its reach into key Chinese markets.
Beijing Med-Pharm Chief Financial Officer Fred Powell: An Interview With PharmAsia News (Part 1 of 2)
Fred Powell is Chief Financial Officer for Beijing Med-Pharm Corp. (BMP), which offers end-to-end solutions - including pre-market entry analysis, clinical trial management, registration, marketing and distribution - to Western pharmaceutical companies interested in selling their products in China.
Conversation On Medicare: The Prescription Drug Benefit: Preparing For What Lies Ahead
"The Pink Sheet" editors met with reimbursement experts Grant Bagley, a partner with Arnold & Porter, LLP in Washington, D.C., and Rosemary Maxwell, Arnold & Porter counsel, in January to discuss how the drug industry can prepare for and will be affected by the major changes stemming from the Medicare Modernization Act of 2003.